Effect of Ketogenic Diet on Selected Cardiometabolic-Related Diseases

Faith Ogbonnaya; Olutayo S. Shokunbi

doi:10.47419/bjbabs.v6i02.287

Authors

Faith Ogbonnaya Biochemistry, School of Basic Medical Sciences, Babcock University, Ilishan, Nigeria
Olutayo S. Shokunbi Biochemistry, School of Basic Medical Sciences, Babcock University, Ilishan, Nigeria

DOI:

https://doi.org/10.47419/bjbabs.v6i02.287

Keywords:

Ketogenic Diet, Type 2 Diabetes Mellitus , Cardiometabolic Disease

Abstract

Cardiometabolic diseases (CMDs) are a group of metabolic abnormalities that increase the risk of diseases such as type 2 diabetes, cardiovascular diseases, insulin resistance, non-alcoholic fatty liver disease (NAFLD), dyslipidemia, and abdominal obesity. The study of CMDs’ comorbidity is an emerging field. In the quest to reduce the cost and side effects of drugs, fasting therapies like the ketogenic diet (KD) have been proposed for treating seizure disorders, cancer, and chronic diseases. Recently, it has been reported to improve the quality of life of patients with cardiometabolic-related diseases. KD is a very low-carbohydrate, high-protein, very high-fat diet that induces ketogenesis, eliciting molecular signals. Intake of KD produces inhibition of histone deacetylase and 3-hydroxy-3-methyl glutaryl coA (HMG-CoA) reductase. It also increases the particulate size of low density lipoprotein cholesterol (LDL-C), lipolysis, HMG-CoA synthase 2, cataplerotic activity, high-density lipoprotein, and sirtuin production, which results in improved health status for patients with NAFLD, diabetes, and cardiovascular diseases when KD is consumed for a minimum of two weeks. There are usually mild side effects that are experienced with this therapy, but these can be overcome after four (4) weeks of continuous intake of KD and with certain interventions like vitamins, minerals, and calcium. There is, therefore, a need to explore ways of incorporating KD into the clinical management and treatment of cardiometabolic diseases globally.

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Tapsell LC, Neale EP, Satija A, Hu FB. Foods, nutrients, and dietary patterns: interconnections and implications for dietary guidelines. Advances in Nutrition. 2016;7(3):445–454. 10.3945/an.115.011718.

Toprak İ, Güler H, Genç AS, Erbaş O. Effects of Ketone Bodies on the Brain. Journal of Experimental and Basic Medical Sciences. 2022;3(2):97–102. 10.5606/jebms.2022.1015.

Kwon HE, Kim HD. Recent aspects of ketogenic diet in neurological disorders. Acta Epileptologica. 2021;3(21). 10.1186/s42494-021-00053-1.

Wheless JW. History of the ketogenic diet. Epilepsia. 2008;49:3–5. 10.1111/j.1528- 1167.2008.01821.x.

Kayode OT, Rotimi DE, Afolayan OA, Kayode AA. Ketogenic diet: A Nutritional remedy for some metabolic disorders. Journal of Education Health and Sport. 2020;10(8):2391–8306. 10.12775/JEHS.2020.10.08.021.

Zhu H, Dexi BD, Youhua ZY, Cheng KC, Jiahao DJ, Xiawei WX, et al. Keto- genic diet for human diseases: the underlying mechanisms and potential for clin- ical implementations. Signal Transduction and Targeted Therapy. 2022;7(1):11–11. 10.1038/s41392-021-00831-w.

Longo R, Peri C, Cricrì D, Coppi L, Caruso D, Mitro N, et al. Ketogenic Diet: A New Light Shining on Old but Gold Biochemistry. Nutrients. 2019;11(10):2497–2497. 10.3390/nu11102497.

Ungaro P, Nettore IC, Franchini F, Palatucci G, Muscogiuri G, Colao A, et al. Epigenome Modulation Induced by Ketogenic Diets. Nutrients. 2022;14(15):3245– 3245. 10.3390/nu14153245.

Morris G, Maes M, Berk M, Carvalho AF, Puri BK. Nutritional ketosis as an inter- vention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders. Eur Psychiatry. 2020;63(1):e8– e8. 10.1192/j.eurpsy.2019.13.

Gerhauser C. Impact of dietary gut microbial metabolites on the epigenome. Philosophical Transactions of the Royal Society B: Biological Sciences. 2018;373(1748):20170359–20170359. 10.1098/rstb.2017.0359.

Newman JC, Verdin E. β-Hydroxybutyrate: a signaling metabolite. Annual Review. 2017;37:51–76. 10.1146/annurev-nutr-071816-064916.

Dowis K, Banga S. The potential health benefits of the ketogenic diet: A narrative review. Nutrients. 2021;13(5):1654–1654. 10.3390/nu13051654.

Miller VJ, Villamena FA, Volek JS. Nutritional ketosis and mitohormesis: potential implications for mitochondrial function and human health. Journal of Nutrition and Metabolism. 2018;p. 5157645–5157645. 10.1155/2018/5157645.

Moreno CL, Mobbs CV. Epigenetic mechanisms underlying lifespan and age- related effects of dietary restriction and the ketogenic diet. Molecular and Cellular Endocrinology. 2017;5(455):33–40. 10.1016/j.mce.2016.11.013.

Muller C. Diabetes, American Chemistry Society Pharmacology & Translation Sci- ence. vol. 5 of 8; 2022. p. 513–691.

Caradonna F, Consiglio O, Luparello C, Gentile C. Science and healthy meals in the world: Nutritional epigenomics and nutrigenetics of the mediterranean diet. Nutri- ents. 2020;12(6):1748–1748. 10.3390/nu12061748.

Yamada K, Takizawa S, Ohgaku Y, Asami T, Furuya K, Yamamoto K, et al. MicroRNA 16-5p is upregulated in calorie-restricted mice and modulates inflammatory cytokines of macrophages. Gene. 2020;725:144191–144191. 10.1016/j.gene.2019.144191.

Cannataro R, Caroleo MC, Fazio A, Torre CL, Plastina P, Gallelli L, et al. Ketogenic diet and microRNAs linked to antioxidant biochemical homeostasis. Antioxidants. 2019;8(8):269–269. 10.3390/antiox8080269.

Kim CW, Aronow WS, Frishman WH. Coronavirus Disease 2019 and Cardiometabolic Disease. Cardiology in Review. 2022;30(3):123–128. 10.1097/CRD.0000000000000405.

Dashti HM, Mathew TC, Zaid NS. Efficacy of low-carbohydrate ketogenic diet in the treatment of type 2 diabetes. Medical Principles and Practice. 2021;30(3):223–235. 10.1159/000512142.

Riazi K, Azhari H, Charette JH, Underwood FE, King JA, Afshar EE, et al. The preva- lence and incidence of NAFLD worldwide: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2022;7(9):851–861. 10.1016/S2468- 1253(22)00165-0.

Paruk IM, Pirie FJ, Motala AA. Non-alcoholic fatty liver disease in Africa: a hidden danger. Global Health, Epidemiology and Genomics. 2019;4:1–4. 10.1017/gheg.2019.2.

Ezema IC, Uchenwoke GM, Ugwueze IUC, Ugueze CU, Uduonu EU, Okezue NC, et al.; 2021.

Fan JG, Kim SU, Wong VWS. New trends on obesity and NAFLD in Asia. Journal of hepatology. 2017;67(4):862–873. 10.1016/j.jhep.2017.06.003.

Sripongpun P, Chaitong C, Chalermrat BC. Current Evidence Concerning Effects of Ketogenic Diet and Intermittent Fasting in Patients with Nonalcoholic Fatty Liver. Journal of Clinical and Translational Hepatology. 2022;10(4):730–739. 10.14218/JCTH.2021.00494.

Alharbi A, Al-Sowayan NS. The Effect of Ketogenic-Diet on Health. Food and Nutri- tion Sciences. 2020;11(4):301–313. 10.4236/fns.2020.114022.

Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mecha- nisms and approach to target organ protection. The journal of clinical hypertension. 2011;13(4):244–251. 10.1111/j.1751-7176.2011.00434.x.

Leow ZX, Guelfi KJ, Davis EA, Jones TW, Fournier PA. The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia. Diabet Med. 2018;35:1258–63. 10.1111/dme.13663.

Schneider S, Biggerstaff DL, Barber TM. Helpful or harmful? The impact of the ketogenic diet on eating disorder outcomes in type 1 diabetes mel- litus. Expert Review of Endocrinology & Metabolism. 2022;17(4):319–331. 10.1080/17446651.2022.2089112.

Vilar-Gomez E, Athinarayanan SJ, Adams RN, Hallberg SJ, Bhanpuri NH, Mcken- zie AL, et al. Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study. British Medical Journal. 2019;9(2):23597–23597. 10.1136/bmjopen-2018- 023597.

Hall KD, Chen KY, Guo J, Lam YY, Leibel RL, Mayer LE, et al. Energy expenditure and body composition changes after an isocaloric ketogenic diet in overweight and obese men. Am J Clin Nutr;104(2):324–333. 10.3945/ajcn.116.133561.

Subramaniam A, Park B, Raphael D, Landstrom M, Hayes KC. Dietary Carbo- hydrate as Glycemic Load, Not Fat, Coupled with Genetic Permissiveness Favor- ing Rapid Growth and Extra Calories, Dictate Metabolic Syndrome and Diabetes Induction in Nile Rats (Arvicanthis niloticus). Nutrients. 2022;14(15):3064–3064. 10.3390/nu14153064.

Goldenberg JZ, Day A, Brinkworth GD, Sato J, Yamada S, Jönsson T, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: sys- tematic review and meta- analysis of published and unpublished randomized trial data. British Medical Journal. 2021;p. 372–372. 10.1136/bmj.m4743.

Tinguely D, Gross J, Kosinski C. Efficacy of Ketogenic Diets on Type 2 Diabetes: a Systematic Review. Current Diabetic Reports. 2021;21(9):32–32. 10.1007/s11892- 021-01399-z.

Yuan X, Wang J, Yang S, Gao M, Cao L, Li X, et al. Effect of the ketogenic diet on glycemic control, insulin resistance, and lipid metabolism in patients with T2DM: a systematic review and meta-analysis. Nutrition & Diabetes. 2020;10(1):38–38. 10.1038/s41387-020-00142-z.

Kephart WC, Pledge CD, Roberson PA, Mumford PW, Romero MA, Mobley CB, et al. The three-month effects of a ketogenic diet on body composition, blood parameters, and performance metrics in CrossFit Trainees: a pilot study. Sports. 2018;6(1):1–1. 10.3390/sports6010001.

Crosby L, Davis B, Joshi S, Jardine M, Paul J, Neola M, et al. Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks. Front Nutr . 2021;8:702802–702802. 10.3389/fnut.2021.702802.

Selvaraj S, Kelly DP, Margulies KB. Implications of Altered Ketone Metabolism and Therapeutic Ketosis in Heart Failure. Circulation . 2020;141(22):1800–1812. 10.1161/CIRCULATIONAHA.119.045033.